Table 3.
hbmMSC, Undifferentiated—High Abundance Analytes | |||
---|---|---|---|
Associated KEGG-Pathway | p-Value | Analytes Involved (Entrez Gene ID) | Predicted Genes (Entrez Gene ID) |
Complement and coagulation cascades | 3.8 × 10−5 | SerpinE1 (5054) Complement factor D (1675) PLAT (5327) PLG (5340) PLAU (5328) |
IGF1 (3479) IGF2 (3481) PLAU (5328) IL-17RA (23,765) CCR2 (1231) PLAT (5327) PLG (5340) PRDM1 (639) PDGFRA (5156) CD47 (961) |
p53 signalling pathway | 9.3 × 10−4 | IGF1 (3479) IGFBP-3 (3486) Serpin E1 (5054) Thrombospondin 1 (7057) |
|
Prostate cancer | 2.0 × 10−3 | IGF1 (3479) IGF2 (3481) PDGF AA (5154) PDGFRA (5156) |
|
Cytokine-cytokine receptor interaction | 6.0 × 10−3 | PDGF AA (5154) PDGFRA (5156) IL-17 (3506) IL-17RA (23,765) MCP-1 (6347) |
|
Glioma | 1.4 × 10−2 | IGF1 (3479) PDGF AA (5154) PDGFRA (5156) |
|
Melanoma | 1.8 × 10−2 | IGF1 (3479) PDGF AA (5154) PDGFRA (5156) |
|
Focal adhesion | 1.9 × 10−2 | IGF1 (3479) PDGF AA (5154) PDGFRA (5156) Thrombospondin 1 (7057) |
|
hsubMSC, Undifferentiated-High Abundance Analytes | |||
Associated KEGG-Pathway | p-Value | Analytes Involved (Entrez Gene ID) | Predicted Genes (Entrez Gene ID) |
Cytokine-cytokine receptor interaction | 6.0 × 10−5 | IL-17 (3506) IL-17RA (23,765) MCP-1 (6347) ENA-78 (6374) IL-8 (3576) CXCR1 (3577) CXCR2 (3579) |
LRP5 (4041) LRP6 (4040) CXCR1 (3577) CXCR2 (3579) PLAU (5328) PLAT (5327) PLG (5340) CCR2 (1231) IL-17RA (23,765) RELA (5970) |
Chemokine signalling pathway | 1.4 × 10−4 | MCP-1 (6347) ENA-78 (6374) IL-8 (3576) CXCR1 (3577) CXCR2 (3579) RELA (5970) |
|
Epithelial cell signalling in Helicobacter pylori infection | 9.3 × 10−4 | IL-8 (3576) CXCR1 (3577) CXCR2 (3579) RELA (5970) |
|
Complement and coagulation cascades | 9.7 × 10−4 | PLAU (5328) PLAT (5327) PLG (5340) Serpin E1 (5054) |
|
NOD-like receptor signalling pathway | 1.4 × 10−2 | MCP-1 (6347) RELA (5970) IL-8 (3576) |
|
Wnt signalling pathway | 7.1 × 10−2 | Dkk-1 (22,943) LRP5 (4041) LRP6 (4040) |